Business Description
QUIA PHARMA AB
ISIN : SE0020678159
Total Employee Number:
2Compare
Compare
Traded in other countries / regions
99B0.GermanyQUIA.Sweden IPO Date
2020-12-14Description
QUIA PHARMA AB is a development company for pharmaceuticals based on a patented drug delivery platform, Uni-Qleaver. The company develops improved and patentable forms of drugs under development or already approved by pharmaceutical authorities. These refined and enhanced forms of medicine are based on the Company's exceptional and patented technology platform. In addition to this, the Company offers multinational sales of omega-3, astaxin and collagen through Amazon.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.01 | |||||
Equity-to-Asset | 0.42 | |||||
Debt-to-Equity | 0.08 | |||||
Debt-to-EBITDA | -0.06 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 90.4 | |||||
3-Year EPS without NRI Growth Rate | 87.4 | |||||
3-Year FCF Growth Rate | 92.2 | |||||
3-Year Book Growth Rate | -20.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
12-1 Month Momentum % | -66.67 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.09 | |||||
Quick Ratio | 0.09 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -891.4 | |||||
Shareholder Yield % | 1209.92 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -158.44 | |||||
ROA % | -110.39 | |||||
ROIC % | -104.02 | |||||
3-Year ROIIC % | 1695.64 | |||||
ROC (Joel Greenblatt) % | -24896.42 | |||||
ROCE % | -157.22 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 0.25 | |||||
EV-to-EBIT | -0.05 | |||||
EV-to-EBITDA | -0.16 | |||||
EV-to-FCF | -0.17 | |||||
Earnings Yield (Greenblatt) % | -2000 | |||||
FCF Yield % | -575.8 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
QUIA PHARMA AB Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.001 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | -0.33 | ||
| 3-Year Sortino Ratio | -0.54 | ||
| Volatility % | 75 | ||
| 14-Day RSI | - | ||
| 14-Day ATR (€) | 0.000007 | ||
| 20-Day SMA (€) | 0.0001 | ||
| 12-1 Month Momentum % | -66.67 | ||
| 52-Week Range (€) | 0.0001 - 0.0007 | ||
| Shares Outstanding (Mil) | 2,620.38 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
QUIA PHARMA AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
QUIA PHARMA AB Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Second quarter earnings results for 2026 | 2026-08-28 | In 52 days | ||
| General meeting for 2025 | 2026-06-26 10:30 | 0.00 (+0.00%) | ||
| Annual report for 2025 | 2026-06-05 | 0.00 (+0.00%) | ||
| Fourth quarter earnings results for 2025 | 2026-03-12 | 0.00 (+0.00%) | ||
| Second quarter earnings results for 2025 | 2025-08-29 | 0.00 (+0.00%) | ||
| General meeting for 2024 | 2025-06-26 10:30 | 0.00 (+0.00%) | ||
| Annual report for 2024 | 2025-06-05 | 0.00 (+0.00%) | ||
| Fourth quarter earnings results for 2024 | 2025-02-26 | 0.00 (+0.00%) | ||
| Second quarter earnings results for 2024 | 2024-08-29 | 0.00 (+25.93%) | ||
| 0.01:1 Stock Split | 2023-08-01 | 0.02 (+0.00%) |
Show
Entries
QUIA PHARMA AB Frequently Asked Questions
What is QUIA PHARMA AB(FRA:99B0)'s stock price today?
The current price of FRA:99B0 is €0.00. The 52 week high of FRA:99B0 is €0.00 and 52 week low is €0.00.
When is next earnings date of QUIA PHARMA AB(FRA:99B0)?
The next earnings date of QUIA PHARMA AB(FRA:99B0) is 2026-08-28 Est..
Does QUIA PHARMA AB(FRA:99B0) pay dividends? If so, how much?
QUIA PHARMA AB(FRA:99B0) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on QUIA PHARMA AB
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers